• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CHRISTOPH MIETHKE GMBH & CO KG PROGAV 2.0 SYS PED.W/SA20 A.PRECHAMBER; HYDROCEPHALUS MANAGEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CHRISTOPH MIETHKE GMBH & CO KG PROGAV 2.0 SYS PED.W/SA20 A.PRECHAMBER; HYDROCEPHALUS MANAGEMENT Back to Search Results
Model Number FX441T
Device Problem Infusion or Flow Problem (2964)
Patient Problem Hydrocephalus (3272)
Event Date 07/24/2021
Event Type  Death  
Manufacturer Narrative
Additional information/ investigation result will be submitted in a supplemental report.
 
Event Description
According to the complainant a progav 2.0 shuntsystem has a blockage/under-drainage the patient underwent a revision procedure on (b)(6) 2021.After the operation the patient died.No further product information available.Age: (b)(6).Height: unknown.Weight: unknown.Gender: female.
 
Manufacturer Narrative
Additional information: b5 investigation: an investigation was not possible because we have not received sample for investigation.According to the clinic, it was sent to us.Unfortunately, we have not received the sample.A request for investigation made at the german post office, was without feedback.The product details (lot, serial number) are also not known to us.However, it is possible that protein deposits inside the valve affect the function of the progav 2.0 shuntsystem.As described in scientific literature, the problem encountered is one of the known, inevitable risks of hc-therapy by shunt implants.
 
Event Description
Additional information: a patient died after a revision surgery of hypoxic brain damage in the hospital stuttgart.We know through this report that the comatose patient was brought to the hospital stuttgart on (b)(6) 2021.Computed tomography showed a significantly dilated ventricular system.This resulted in a revision of the shunt.The shunt was found barely permeable.The surgeon inform us that the child had a mentally handicap, but was physically normally developed.Further details on the product were not provided to us.We did not received the product for investigation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROGAV 2.0 SYS PED.W/SA20 A.PRECHAMBER
Type of Device
HYDROCEPHALUS MANAGEMENT
Manufacturer (Section D)
CHRISTOPH MIETHKE GMBH & CO KG
ulanenweg 2
potsdam, 14469
GM  14469
MDR Report Key12546654
MDR Text Key273772977
Report Number3004721439-2021-00256
Device Sequence Number1
Product Code JXG
UDI-Device Identifier04041906137465
UDI-Public4041906137465
Combination Product (y/n)N
PMA/PMN Number
K161853
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,user f
Type of Report Initial,Followup
Report Date 10/07/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/29/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberFX441T
Device Catalogue NumberFX441T
Was Device Available for Evaluation? No
Date Manufacturer Received09/28/2021
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age2 YR
-
-